Titre : Facteur de transcription Oct-3

Facteur de transcription Oct-3 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Evidence-Based Practice
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Facteur de transcription Oct-3 : Questions médicales les plus fréquentes", "headline": "Facteur de transcription Oct-3 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Facteur de transcription Oct-3 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-27", "dateModified": "2025-04-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Facteur de transcription Oct-3" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Facteurs de transcription Oct", "url": "https://questionsmedicales.fr/mesh/D050810", "about": { "@type": "MedicalCondition", "name": "Facteurs de transcription Oct", "code": { "@type": "MedicalCode", "code": "D050810", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.930.710.500" } } }, "about": { "@type": "MedicalCondition", "name": "Facteur de transcription Oct-3", "alternateName": "Octamer Transcription Factor-3", "code": { "@type": "MedicalCode", "code": "D050814", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yang Yang", "url": "https://questionsmedicales.fr/author/Yang%20Yang", "affiliation": { "@type": "Organization", "name": "Abdominal Oncology Ward, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China." } }, { "@type": "Person", "name": "Hao Guo", "url": "https://questionsmedicales.fr/author/Hao%20Guo", "affiliation": { "@type": "Organization", "name": "Qiqihaer Medical University, Qiqihaer, Heilongjiang, 161005, PR China." } }, { "@type": "Person", "name": "Shuwei Hu", "url": "https://questionsmedicales.fr/author/Shuwei%20Hu", "affiliation": { "@type": "Organization", "name": "Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, USA." } }, { "@type": "Person", "name": "Rui Li", "url": "https://questionsmedicales.fr/author/Rui%20Li", "affiliation": { "@type": "Organization", "name": "Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China." } }, { "@type": "Person", "name": "Yanqiao Zhang", "url": "https://questionsmedicales.fr/author/Yanqiao%20Zhang", "affiliation": { "@type": "Organization", "name": "Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Evidence, expertise, and patient/family preferences to maximize health for older adults with implications for evidence-based practice.", "datePublished": "2022-09-14", "url": "https://questionsmedicales.fr/article/36102340", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/wvn.12605" } }, { "@type": "ScholarlyArticle", "name": "Evidence-based practice and clinical practice in child language: an online survey with Brazilian speech-language pathologists.", "datePublished": "2023-11-10", "url": "https://questionsmedicales.fr/article/37970891", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/2317-1782/20232022272pt" } }, { "@type": "ScholarlyArticle", "name": "Enhancing Quality of Care Through Evidence-Based Practice: Training and Supervision Experiences.", "datePublished": "2023-04-07", "url": "https://questionsmedicales.fr/article/37026189", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1176/appi.psychotherapy.20220015" } }, { "@type": "ScholarlyArticle", "name": "Evidence-based practices in developing and maintaining clinical nurse preceptors: An integrative review.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35863086", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.nedt.2022.105468" } }, { "@type": "ScholarlyArticle", "name": "The validity and reliability properties of a Persian version of the evidence-based practice profile (EBP", "datePublished": "2024-10-14", "url": "https://questionsmedicales.fr/article/39402622", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12909-024-06139-x" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Facteurs de transcription", "item": "https://questionsmedicales.fr/mesh/D014157" }, { "@type": "ListItem", "position": 5, "name": "Facteurs de transcription à domaine POU", "item": "https://questionsmedicales.fr/mesh/D050809" }, { "@type": "ListItem", "position": 6, "name": "Facteurs de transcription Oct", "item": "https://questionsmedicales.fr/mesh/D050810" }, { "@type": "ListItem", "position": 7, "name": "Facteur de transcription Oct-3", "item": "https://questionsmedicales.fr/mesh/D050814" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Facteur de transcription Oct-3 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Facteur de transcription Oct-3", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Facteur de transcription Oct-3", "description": "Comment diagnostiquer une anomalie d'Oct-3 ?\nQuels tests sont utilisés pour évaluer Oct-3 ?\nY a-t-il des biomarqueurs associés à Oct-3 ?\nQuels symptômes peuvent indiquer un problème avec Oct-3 ?\nComment l'expression d'Oct-3 est-elle mesurée ?", "url": "https://questionsmedicales.fr/mesh/D050814?mesh_terms=Evidence-Based+Practice&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Facteur de transcription Oct-3", "description": "Quels symptômes sont liés à une dysrégulation d'Oct-3 ?\nOct-3 influence-t-il le développement neurologique ?\nY a-t-il des symptômes associés à des cancers liés à Oct-3 ?\nComment Oct-3 affecte-t-il la fonction immunitaire ?\nDes anomalies de l'Oct-3 peuvent-elles causer des troubles métaboliques ?", "url": "https://questionsmedicales.fr/mesh/D050814?mesh_terms=Evidence-Based+Practice&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Facteur de transcription Oct-3", "description": "Peut-on prévenir les anomalies liées à Oct-3 ?\nY a-t-il des facteurs environnementaux influençant Oct-3 ?\nComment l'alimentation influence-t-elle Oct-3 ?\nDes exercices physiques peuvent-ils influencer Oct-3 ?\nQuelles sont les recommandations pour les femmes enceintes concernant Oct-3 ?", "url": "https://questionsmedicales.fr/mesh/D050814?mesh_terms=Evidence-Based+Practice&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Facteur de transcription Oct-3", "description": "Quels traitements ciblent Oct-3 dans le cancer ?\nPeut-on moduler Oct-3 par des médicaments ?\nY a-t-il des approches de thérapie cellulaire impliquant Oct-3 ?\nComment les thérapies géniques affectent-elles Oct-3 ?\nQuels sont les effets secondaires des traitements ciblant Oct-3 ?", "url": "https://questionsmedicales.fr/mesh/D050814?mesh_terms=Evidence-Based+Practice&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Facteur de transcription Oct-3", "description": "Quelles complications peuvent survenir avec des anomalies d'Oct-3 ?\nLes cancers liés à Oct-3 ont-ils des complications spécifiques ?\nComment les troubles d'Oct-3 affectent-ils la fertilité ?\nY a-t-il des complications neurologiques associées à Oct-3 ?\nLes troubles métaboliques liés à Oct-3 entraînent-ils des complications ?", "url": "https://questionsmedicales.fr/mesh/D050814?mesh_terms=Evidence-Based+Practice&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Facteur de transcription Oct-3", "description": "Quels sont les facteurs de risque pour les anomalies d'Oct-3 ?\nL'âge parental influence-t-il les risques liés à Oct-3 ?\nY a-t-il des maladies génétiques associées à Oct-3 ?\nLes habitudes de vie influencent-elles Oct-3 ?\nDes infections peuvent-elles affecter Oct-3 ?", "url": "https://questionsmedicales.fr/mesh/D050814?mesh_terms=Evidence-Based+Practice&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie d'Oct-3 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses d'expression génique peuvent être utilisés." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer Oct-3 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'immunohistochimie et la PCR en temps réel sont couramment utilisés." } }, { "@type": "Question", "name": "Y a-t-il des biomarqueurs associés à Oct-3 ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux d'Oct-3 peuvent servir de biomarqueurs dans certaines pathologies." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec Oct-3 ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies de développement ou des troubles de différenciation cellulaire peuvent survenir." } }, { "@type": "Question", "name": "Comment l'expression d'Oct-3 est-elle mesurée ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'expression peut être mesurée par RT-PCR ou Western blot pour quantifier la protéine." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une dysrégulation d'Oct-3 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de la croissance et des anomalies morphologiques peuvent être observés." } }, { "@type": "Question", "name": "Oct-3 influence-t-il le développement neurologique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, Oct-3 joue un rôle dans le développement du système nerveux central." } }, { "@type": "Question", "name": "Y a-t-il des symptômes associés à des cancers liés à Oct-3 ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes variés selon le type de cancer, comme des douleurs ou des masses, peuvent apparaître." } }, { "@type": "Question", "name": "Comment Oct-3 affecte-t-il la fonction immunitaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oct-3 régule l'expression des gènes impliqués dans la réponse immunitaire." } }, { "@type": "Question", "name": "Des anomalies de l'Oct-3 peuvent-elles causer des troubles métaboliques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dérèglements peuvent affecter le métabolisme cellulaire et énergétique." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies liées à Oct-3 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une surveillance génétique et des conseils préconceptionnels peuvent aider à prévenir." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux influençant Oct-3 ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains agents chimiques et radiations peuvent affecter l'expression d'Oct-3." } }, { "@type": "Question", "name": "Comment l'alimentation influence-t-elle Oct-3 ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la régulation des facteurs de transcription comme Oct-3." } }, { "@type": "Question", "name": "Des exercices physiques peuvent-ils influencer Oct-3 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier peut moduler l'expression de certains gènes, y compris Oct-3." } }, { "@type": "Question", "name": "Quelles sont les recommandations pour les femmes enceintes concernant Oct-3 ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les toxines et suivre un suivi médical régulier peut aider à prévenir des anomalies." } }, { "@type": "Question", "name": "Quels traitements ciblent Oct-3 dans le cancer ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des inhibiteurs de signalisation peuvent être utilisés." } }, { "@type": "Question", "name": "Peut-on moduler Oct-3 par des médicaments ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certaines molécules peuvent influencer l'expression d'Oct-3, mais la recherche est en cours." } }, { "@type": "Question", "name": "Y a-t-il des approches de thérapie cellulaire impliquant Oct-3 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des cellules souches modifiées exprimant Oct-3 sont explorées pour des thérapies." } }, { "@type": "Question", "name": "Comment les thérapies géniques affectent-elles Oct-3 ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent corriger des mutations ou réguler l'expression d'Oct-3 dans les cellules." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ciblant Oct-3 ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des réactions immunitaires et des troubles métaboliques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des anomalies d'Oct-3 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des malformations congénitales et des troubles du développement." } }, { "@type": "Question", "name": "Les cancers liés à Oct-3 ont-ils des complications spécifiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications comme la métastase et la résistance au traitement peuvent survenir." } }, { "@type": "Question", "name": "Comment les troubles d'Oct-3 affectent-ils la fertilité ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies peuvent entraîner des problèmes de fertilité et des complications de grossesse." } }, { "@type": "Question", "name": "Y a-t-il des complications neurologiques associées à Oct-3 ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles neurologiques peuvent résulter d'une dysrégulation d'Oct-3." } }, { "@type": "Question", "name": "Les troubles métaboliques liés à Oct-3 entraînent-ils des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent causer des complications comme le diabète ou des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies d'Oct-3 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux et des expositions environnementales sont des facteurs de risque." } }, { "@type": "Question", "name": "L'âge parental influence-t-il les risques liés à Oct-3 ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge avancé des parents peut augmenter le risque d'anomalies génétiques." } }, { "@type": "Question", "name": "Y a-t-il des maladies génétiques associées à Oct-3 ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies comme le syndrome de Down peuvent être liées à des anomalies d'Oct-3." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles Oct-3 ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme et l'alcool peuvent affecter l'expression d'Oct-3 et augmenter les risques." } }, { "@type": "Question", "name": "Des infections peuvent-elles affecter Oct-3 ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales peuvent perturber l'expression d'Oct-3 dans les cellules." } } ] } ] }

Sources (10000 au total)

Evidence, expertise, and patient/family preferences to maximize health for older adults with implications for evidence-based practice.

As Americans live longer and with chronic conditions, the healthcare system, researchers, faculty, practicing providers, patients, and families must adapt to changing societal needs and goals.... The aim of this commentary was to offer recommendations that align with the six vital directions to improve the health care and quality of life for older Americans.... This article expands upon the six vital directions from an evidence-based practice (EBP) perspective that values the three legs of the EBP stool: (1) research evidence, (2) clinician expertise, and (3... The recommendations reflect the scientific literature, our expertise in EBP and research, our nursing roles and expertise, and our experiences in the care of our older parents. By sharing our experien... Vital directions for improving the health care and quality of life for older Americans include promoting interprofessional education to create an adequately prepared workforce; researching and impleme...

Evidence-based practice and clinical practice in child language: an online survey with Brazilian speech-language pathologists.

To characterize the knowledge, skills, opinions, and main barriers perceived by speech-language pathologists, in child language in Brazil, regarding evidence-based practice (EBP).... The study was conducted between August 2021 and July 2022 using an online questionnaire. In addition to sociodemographic and field data, 22 items related to EBP were considered and subdivided into "kn... Although most speech-language pathologists report having learned the basics of EBP in their academic training, there are weaknesses in their knowledge and lack of mastery of search strategies and crit... This study alerts the academic community to the urgency of considering EBP in the context of Brazilian Speech-Language Pathology....

Enhancing Quality of Care Through Evidence-Based Practice: Training and Supervision Experiences.

Evidence-based practice (EBP) is the preferred approach to treatment in mental health settings because it involves the integration of the best available research, clinical expertise, and patient value... Electronic surveys were completed by 69 therapists, most of whom had a master's degree, within a psychiatry and behavioral sciences department at an academic institution. Participating therapists were... Although most therapists reported completing some form of EST-related coursework, a majority did not receive any supervision related to implementation of ESTs (51% for cognitive-behavioral therapy cas... Although research from the past decade has supported the need for improvements in training on ESTs, and especially in supervision, problems related to limited exposure to training and supervision amon...

Evidence-based practices in developing and maintaining clinical nurse preceptors: An integrative review.

This integrative review of literature explores the best practice for establishing and maintaining a hospital-based nurse preceptor program. The intent is to provide nurse leadership and educators with... The project team conducted an integrative review of literature to inform best practice using the Johns Hopkins Evidence-Based Practice Model and Guidelines.... Data sources included the PubMed, CINAHL, and Cochrane databases.... Each applicable article underwent a rigorous review and appraisal by the project team. The team used the Johns Hopkins Evidence-Based Practice Model to guide the appraisal process and to synthesize re... The search yielded 115 unique articles that answered the evidence-based practice question. What are best practices for establishing and maintaining a hospital-based nursing preceptor program? Due to t... Many preceptorship themes and recommendations resonate throughout multiple levels of evidence. Recommendations include implementing an evidence-based, standardized curriculum that features diverse tea...

The validity and reliability properties of a Persian version of the evidence-based practice profile (EBP

Evidence-based medicine is defined as searching for medical information, reviewing and comparing it to each patient's situation, and then judging the optimal decision. We aimed to measure the psychome... This cross-sectional study was conducted in 2021. The EBP2 questionnaire, which includes 74 five-Likert-scale items, was translated into the Persian language using the forward-backward translation met... Overall, 339 students participated in this study. The cultural adaptability, linguistic equivalence, and content validity of the Persian version of the EBP... The study's findings indicate that the Persian translated of the EBP2 questionnaire exhibited satisfactory validity and reliability for assessing students' evidence-based performance in health-related...

The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder.

The objective of this article was to provide an overview of the development and recommendations from the Australian evidence-based clinical practice guideline for attention deficit hyperactivity disor... Development integrated the best available evidence with multidisciplinary clinical expertise and the preferences of those with lived experience, underpinned by the Grading of Recommendations, Assessme... The 113 clinical recommendations apply to young children (5 years and under), children, adolescents and adults. They provide guidance for clinicians on identification, screening, diagnosis, multimodal... The guideline was approved by the National Health and Medical Research Council (NHMRC) of Australia and relevant medical and allied health professional associations. It is anticipated that successful ...

The perspectives of Australian speech pathologists in providing evidence-based practices to children with autism.

Bridging the research-practice gap in autism communication services is an identified priority for improving services. Limited research has investigated the views of practitioners regarding this resear... To elucidate how Australian speech pathologists engage with external evidence and how communication outcomes are measured to demonstrate the effectiveness of service provision to children with autism.... A total of 15 Australian speech pathologists, with experience ranging from less than 1 to more than 16 years, participated in three focus groups. Data from focus groups were analysed using reflexive t... Seven themes were identified. Participants reported on the diversity of individuals with autism, their experiences of resource constraints, seeking collegial advice and accessing a diverse range of ev... Individual practitioner skill and beliefs are facilitators to translating research to practice. Interventions to improve clinician use of EBP should address the skill and belief barriers, aiming to in... What is already known on the subject Constrained resources, especially lack of time, is a barrier to routine uptake of best available evidence in clinical services for children with autism. What this ...

Knowledge, attitude, understanding and implementation of evidence-based practice among Jordanian radiographers.

Evidence-based practice (EBP) has gained attention globally from healthcare professionals and researchers. The aim of this study was to assess Jordanian diagnostic radiographers' knowledge, attitude, ... A paper-based, self-administered questionnaire with two sections was used. The first section included 11 socio-demographic questions and the second section contained 56 questions regarding EBP categor... Responses were received from 203 radiographers, most of them 135 (66.5%) aged 21-30 years. The majority of radiographers agreed or strongly agreed that the application of EBP is necessary for radiogra... This study showed that despite the positive attitude, and beliefs of radiographers toward EBP, and access to information resources, radiographers still need a higher level of confidence in their abili... The findings of this study may help inform restructure of the undergraduate radiography curriculum, training programs or other interventions required to promote or facilitate the adoption of EBP in Jo...